Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
908 DevicesMASS +0.36%71 Equity-to-Asset is 0.72 as of Mar. 2026, which is 8% below its 10-year median of 0.78. GuruFocus rates MASS with a GF Score™ of 71/100 and a GF Value™ of $7.08 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 853 Medical Devices & Instruments companies, 908 Devices ranks better than 62.84% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. 908 Devices's Total Stockholders Equity for the quarter that ended in Mar. 2026 was $134.17 Mil. 908 Devices's Total Assets for the quarter that ended in Mar. 2026 was $186.70 Mil.
Therefore, 908 Devices's Equity to Asset Ratio for the quarter that ended in Mar. 2026 was 0.72.
The historical rank and industry rank for 908 Devices's Equity-to-Asset or its related term are showing as below:
MASS'
s Equity-to-Asset Range Over the Past 10 Years
Min: -1.81 Med: 0.78 Max: 0.83
Current: 0.72
During the past 8 years, the highest Equity to Asset Ratio of 908 Devices was 0.83. The lowest was -1.81. And the median was 0.78.
MASS's Equity-to-Asset is ranked better than 62.84% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 0.64
vs MASS: 0.72
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
908 Devices Equity-to-Asset Related Terms
908 Devices Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for 908 Devices's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MASS vs ELMD, SGHT, LAB: Equity-to-Asset Comparison
For the Medical Devices subindustry, 908 Devices's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
908 Devices Equity-to-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, 908 Devices's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where 908 Devices's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
908 Devices's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
908 Devices (MASS) has a Equity-to-Asset of 0.72 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on 908 Devices and its competitors. This is near median its historical median of 0.78. According to the industry distribution chart, 908 Devices ranks #317 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 37.2%.
Is 908 Devices' Equity-to-Asset too high?
908 Devices' current Equity-to-Asset of 0.72 is near median its 10-year median of 0.78. The Medical Devices & Instruments industry median Equity-to-Asset is 0.64. 908 Devices' value of 0.72 is 12.5% above this industry median. Based on the distribution chart, 908 Devices ranks #317 out of 853 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, 908 Devices has a GF Score™ of 71/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does 908 Devices' Equity-to-Asset compare to ELMD and SGHT?
According to the Medical Devices & Instruments industry distribution chart, 908 Devices ranks #317 out of 853 companies for Equity-to-Asset. This puts 908 Devices in the upper half of its industry. The industry median Equity-to-Asset is 0.64. 908 Devices' value of 0.72 is 12.5% above this benchmark. While the company's 10-year median is 0.78 vs. the industry median of 0.64, 908 Devices has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Devices & Instruments company?
The median Equity-to-Asset among Medical Devices & Instruments companies is 0.64, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. 908 Devices's current Equity-to-Asset of 0.72 is 12.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on 908 Devices and its competitors. For the Medical Devices & Instruments industry, the median Equity-to-Asset is 0.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 908 Devices's current Equity-to-Asset is 0.72, which is near median its own 10-year median of 0.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 908 Devices stock overvalued right now?
Based on GuruFocus' analysis, 908 Devices (MASS) is currently considered Modestly Overvalued. The stock's GF Value™ is $7.08, compared to a current price of $8.44 — trading 19.2% above its estimated fair value. The current Equity-to-Asset is 0.72, which is near median its 10-year median of 0.78 and 12.5% above the Medical Devices & Instruments industry median of 0.64. 908 Devices' overall GF Score™ is 71/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For 908 Devices (MASS), the current Equity-to-Asset is 0.72 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is 908 Devices (MASS) Overvalued in 2026?
Based on GuruFocus' analysis, 908 Devices stock appears to be overvalued.
The current stock price of $8.44 is trading 19.2% above its estimated GF Value™ of $7.08.
GuruFocus considers 908 Devices to be Modestly Overvalued.
Key valuation signals for MASS:
Equity-to-Asset: 0.72 (near median its 10-year median of 0.78)
GF Value™: $7.08 vs. price of $8.44 (19.2% above fair value)
Industry Position: 12.5% above the Medical Devices & Instruments median (#317 of 853)
No single metric tells the full story. See the MASS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.
71GF Score
Get the complete analysis for MASS
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MASS has been successfully added to your 
